Contact this trialFirst, we need to learn more about you.
Peptide
BMN 111 for Achondroplasia
Recruiting2 awardsPhase 3
Cincinnati, Ohio
This trial is testing if a new drug, BMN 111, is a safe and effective treatment for children with achondroplasia.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.